TY - JOUR
T1 - Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder
AU - Nunez, Nicolas A.
AU - Coombes, Brandon J.
AU - Romo-Nava, Francisco
AU - Bond, David J.
AU - Vande Voort, Jennifer
AU - Croarkin, Paul E.
AU - Leibman, Nicole
AU - Gardea Resendez, Manuel
AU - Veldic, Marin
AU - Betcher, Hannah
AU - Singh, Balwinder
AU - Colby, Colin
AU - Cuellar-Barboza, Alfredo
AU - Prieto, Miguel
AU - Moore, Katherine M.
AU - Ozerdem, Aysegul
AU - McElroy, Susan L.
AU - Frye, Mark A.
AU - Biernacka, Joanna M.
N1 - Publisher Copyright:
Copyright © 2022 Nunez, Coombes, Romo-Nava, Bond, Vande Voort, Croarkin, Leibman, Gardea Resendez, Veldic, Betcher, Singh, Colby, Cuellar-Barboza, Prieto, Moore, Ozerdem, McElroy, Frye and Biernacka.
PY - 2022/4/14
Y1 - 2022/4/14
N2 - Background: Bipolar disorder (BD) with co-occurring attention deficit-hyperactivity disorder (ADHD) is associated with an unfavorable course of illness. We aimed to identify potential clinical and genetic correlates of BD with and without ADHD. Methods: Among patients with BD (N = 2,198) enrolled in the Mayo Clinic Bipolar Biobank we identified those with ADHD diagnosed in childhood (BD+cADHD; N = 350), those with adult-onset attention deficit symptoms (BD+aAD; N = 254), and those without ADHD (N = 1,594). We compared the groups using linear or logistic regression adjusting for age, sex, and recruitment site. For genotyped patients (N = 1,443), logistic regression was used to compare ADHD and BD polygenic risk scores (PRSs) between the BD groups, as well as to non-BD controls (N = 777). Results: Compared to the non-ADHD BD group, BD+cADHD patients were younger, more often men and had a greater number of co-occurring anxiety and substance use disorders (all p < 0.001). Additionally, BD+cADHD patients had poorer responses to lithium and lamotrigine (p = 0.005 and p = 0.007, respectively). In PRS analyses, all BD patient subsets had greater genetic risk for BD and ADHD when compared to non-BD controls (p < 0.001 in all comparisons). BD+cADHD patients had a higher ADHD-PRS than non-ADHD BD patients (p = 0.012). However, BD+aAD patients showed no evidence of higher ADHD-PRS than non-ADHD BD patients (p = 0.38). Conclusions: BD+cADHD was associated with a greater number of comorbidities and reduced response to mood stabilizing treatments. The higher ADHD PRS for the BD+cADHD group may reflect a greater influence of genetic factors on early presentation of ADHD symptoms.
AB - Background: Bipolar disorder (BD) with co-occurring attention deficit-hyperactivity disorder (ADHD) is associated with an unfavorable course of illness. We aimed to identify potential clinical and genetic correlates of BD with and without ADHD. Methods: Among patients with BD (N = 2,198) enrolled in the Mayo Clinic Bipolar Biobank we identified those with ADHD diagnosed in childhood (BD+cADHD; N = 350), those with adult-onset attention deficit symptoms (BD+aAD; N = 254), and those without ADHD (N = 1,594). We compared the groups using linear or logistic regression adjusting for age, sex, and recruitment site. For genotyped patients (N = 1,443), logistic regression was used to compare ADHD and BD polygenic risk scores (PRSs) between the BD groups, as well as to non-BD controls (N = 777). Results: Compared to the non-ADHD BD group, BD+cADHD patients were younger, more often men and had a greater number of co-occurring anxiety and substance use disorders (all p < 0.001). Additionally, BD+cADHD patients had poorer responses to lithium and lamotrigine (p = 0.005 and p = 0.007, respectively). In PRS analyses, all BD patient subsets had greater genetic risk for BD and ADHD when compared to non-BD controls (p < 0.001 in all comparisons). BD+cADHD patients had a higher ADHD-PRS than non-ADHD BD patients (p = 0.012). However, BD+aAD patients showed no evidence of higher ADHD-PRS than non-ADHD BD patients (p = 0.38). Conclusions: BD+cADHD was associated with a greater number of comorbidities and reduced response to mood stabilizing treatments. The higher ADHD PRS for the BD+cADHD group may reflect a greater influence of genetic factors on early presentation of ADHD symptoms.
KW - ADHD
KW - bipolar disorder
KW - clinical features
KW - genetic
KW - polygenic risk score
UR - http://www.scopus.com/inward/record.url?scp=85129000840&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2022.884217
DO - 10.3389/fpsyt.2022.884217
M3 - Article
C2 - 35492709
AN - SCOPUS:85129000840
SN - 1664-0640
VL - 13
SP - 884217
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 884217
ER -